Tysabri 300mg Injection contains Natalizumab, an immunomodulatory medication used to treat some autoimmune diseases by blocking particular immune system pathways.
In addition to requiring frequent blood, kidney, liver, and heart function tests, this medication may decrease blood cells, raise the risk of infection, and require effective contraception for the duration of therapy, which will be decided by your doctor.
This Product require strict temperature-controlled storage and transportation, as outlined in regulatory guidelines.
Tysabri 300mg Injection contains Natalizumab, an immunomodulatory medication used to treat some autoimmune diseases by blocking particular immune system pathways.
Brand Name: Tysabri
Composition: Natalizumab
Mechanism of Action:
An anti-α4 integrin monoclonal antibody called natalizumab stops immune cells from migrating into the central nervous system (CNS) by preventing white blood cells' α4 integrins from interacting with endothelial cells' vascular cell adhesion molecule-1 (VCAM-1).
Uses:
Dosage and Administration:
Administered via infusion into the vein. Every four weeks, 300 mg is the standard dosage. The infusion is usually administered over a period of one hour.
Side Effects:
Safety Advise:
Lungs 
The safety of Tysabri for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.
Liver
The safety of Tysabri for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.
Kidney
The safety of Tysabri for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.
Pregnancy
Tysabri should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.
Breast Feeding
Using Tysabri while nursing is most likely dangerous. Kindly speak with your healthcare provider.
Storage:
Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
How to use this Medication?
Injection preparations for natalizumab are available as a concentrated liquid solution that a physician or nurse can dilute and administer gradually into a vein. In a licensed infusion facility, it is typically administered once every four weeks. You will receive your full dose of natalizumab injectable product in approximately one hour.
Serious adverse responses to natalizumab are possible at any point throughout treatment, however most usually occur two hours after infusion. Particularly during the first 12 infusions, remain at the infusion facility for monitoring, and notify your doctor or nurse of any symptoms, such as rash, dizziness, hives, or trouble breathing.
Disclaimer:
The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place
Marketer details
Name: Biogen Idec Biotech India Pvt Ltd
Address: A-1/292, Ground Floor Janak Puri New Delhi West Delhi DL 110058 IN
Country of origin: India
We deliver within Bangalore city limits in 24 hours for orders above ₹10,000, with exceptions based on location, while other deliveries rely on trusted courier partners and their timelines.
We provide only authentic, verified medicines sourced from manufacturers or authorized distributors, ensuring proper cold chain storage throughout delivery.
We are available around the clock to assist you.
Shop with confidence, knowing your data is safe with us.
